Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,206
Closed -$1.28M 99
2025
Q4
$1.28M Buy
10,206
+909
+10% +$119K 0.48% 76
2025
Q3
$1.36M Buy
9,297
+94
+1% +$14.2K 0.52% 78
2025
Q2
$1.47M Buy
9,203
+53
+0.6% +$8.4K 0.6% 77
2025
Q1
$1.43M Buy
9,150
+128
+1% +$21.3K 0.66% 77
2024
Q4
$1.47M Buy
9,022
+172
+2% +$30.8K 0.63% 75
2024
Q3
$1.73M Buy
+8,850
New +$1.63M 0.77% 63
2024
Q2
Sell
-8,598
Closed -$1.44M 97
2024
Q1
$1.44M Buy
8,598
+314
+4% +$58.8K 0.7% 75
2023
Q4
$1.63M Buy
8,284
+91
+1% +$16.1K 0.86% 42
2023
Q3
$1.43M Buy
+8,193
New +$1.49M 0.89% 44
2023
Q1
$1.28M Buy
7,866
+116
+1% +$19K 1.17% 38
2022
Q4
$1.22M Sell
7,750
-335
-4% -$49.6K 0.76% 59
2022
Q3
$1.2M Buy
8,085
+385
+5% +$64.3K 0.76% 47
2022
Q2
$1.38M Buy
7,700
+7
+0.1% +$1.21K 0.78% 40
2022
Q1
$1.45M Buy
7,693
+31
+0.4% +$6.13K 0.75% 44
2021
Q4
$1.53M Buy
7,662
+18
+0.2% +$3.94K 0.94% 43
2021
Q3
$1.65M Buy
7,644
+73
+1% +$14.7K 0.91% 47
2021
Q2
$1.51M Buy
7,571
+453
+6% +$78.7K 0.85% 53
2021
Q1
$1.12M Sell
7,118
-6,993
-50% -$1.11M 0.72% 57
2020
Q4
$2.33M Sell
14,111
-1,953
-12% -$318K 1.47% 30
2020
Q3
$2.66M Sell
16,064
-96
-0.6% -$14.8K 1.88% 16
2020
Q2
$2.21M Sell
16,160
-4,389
-21% -$573K 1.88% 24
2020
Q1
$2.42M Sell
20,549
-2,248
-10% -$296K 2.25% 6
2019
Q4
$3.02M Sell
22,797
-1,061
-4% -$132K 2.41% 7
2019
Q3
$2.97M Sell
23,858
-537
-2% -$64.8K 2.52% 5
2019
Q2
$2.77M Buy
24,395
+177
+0.7% +$18.5K 2.33% 7
2019
Q1
$2.44M Sell
24,218
-1,091
-4% -$99.1K 2.25% 10
2018
Q4
$2.17M Buy
25,309
+18
+0.1% +$1.62K 2.37% 14
2018
Q3
$2.32M Sell
25,291
-1,717
-6% -$152K 2.08% 18
2018
Q2
$2.25K Sell
27,008
-250
-0.9% -$21.1K 2.07% 17
2018
Q1
$2.28M Buy
27,258
+145
+0.5% +$11.4K 2.18% 15
2017
Q4
$1.95M Buy
+27,113
New +$1.86M 1.7% 25

Other funds holding ZTS

Altman Advisors's ZTS Position: Q1 2026 in Review

Altman Advisors sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 10,206 shares — an estimated $1.28M sold.

Altman Advisors first reported a position in ZTS in Q4 2017 and held it in 31 quarters. The position peaked at $3.02M in Q4 2019. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Altman Advisors reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
  • Altman Advisors sold 10,206 Zoetis shares in Q1 2026, an estimated $1.28M.
  • Altman Advisors first reported a position in Zoetis in Q4 2017 and held it in 31 quarters.
  • Altman Advisors's Zoetis position peaked at $3.02M in Q4 2019.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Altman Advisors's 13F filing for Q1 2026, filed 5 May 2026.